Coya Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$3.21

+0.05 (+1.58%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +1,048.0% upside

Low Target $27.29

Average Target $36.85

High Target $45.13

Current Price $3.21

Current
$3.21

Target
$36.85

$27.29 $36.85 avg $45.13

Scenario Analysis

Bear Case

$27.29

750.2%

Low target

Base Case

$36.85

+1,048.0%

Avg target

Bull Case

$45.13

+1,305.9%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$6.62

-51.5% from high

52-Week Low

$2.98

+7.7% from low

Target vs 52W High

$36.85

+456.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.5%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-18.5%
MRNA Moderna Inc	Hold	31	32%	$149.45	-35.4%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-91.9%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.7%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-35.3%